Effective exercise for people with Multiple Sclerosis

ISRCTN ISRCTN89009719
DOI https://doi.org/10.1186/ISRCTN89009719
Secondary identifying numbers N/A
Submission date
17/10/2007
Registration date
15/11/2007
Last edited
11/10/2011
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Nervous System Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Johnny Collett
Scientific

Movement science group
School of life sciences
Oxford Brookes University
Gipsy Lane
Headington
Oxford
OX10 0SB
United Kingdom

Phone +44 (0)1865 483272
Email jcollett@brookes.ac.uk

Study information

Study designSingle-blind randomised non-controlled trial
Primary study designInterventional
Secondary study designNon randomised controlled trial
Study setting(s)Not specified
Study typeTreatment
Participant information sheet Not available in web format, please use the contact details below to request a patient information sheet
Scientific titleEffective exercise for people with Multiple Sclerosis: a single-blind randomised non-controlled trial
Study objectivesTo examine the effect of three different forms of exercise delivered over a three-month period. Three exercise groups will perform the same amount of exercise within sessions but it will be delivered in different ways:
1. Shorter and hard (anaerobic)
2. Longer and easy (aerobic)
3. A combination of both aerobic and anaerobic exercises

Please note that as of 11/02/2009 this record was updated to include amended trial dates. The initial trial dates at the time of registration were:
Initial anticipated start date: 01/11/2007
Initial anticipated end date: 01/07/2009
Ethics approval(s)Added 11/02/2009: National Research Ethics Service, Oxfordshire REC A gave approval on the 7th May 2008 (ref: 08/H0604/3)
Health condition(s) or problem(s) studiedMultiple sclerosis
InterventionThree exercise groups will perform the same amount of exercise within sessions delivered in different ways:
1. Shorter and hard (anaerobic)
2. Longer and easy (aerobic)
3. A combination of both aerobic and anaerobic exercises

Total duration of treatment will be the same for each treatment arm. Each participant will have 20 minute exercise sessions 3 x per week for 12 weeks (36 sessions). The total relative work performed (determined from baseline fitness assessment) at each exercise session will be the same for each exercise group but the intensity and delivery of the exercise with be different. An assessment will take place at week 24 (12 weeks after end of intervention).
Intervention typeOther
Primary outcome measureTwo-minute walk distance, measured at baseline, week 6 (half-way intervention), week 12 (end intervention) and week 24 (follow up).
Secondary outcome measures1. Questionnaires:
1.1. Barthel Index of independence in activities of daily living
1.2. Fatigue Severity Scale (FSS): self reported fatigue levels
1.3. Physical Activity Questionnaire in the Elderly (PASE): self reported activity levels in home, work and social environments
1.4. General Health Status questionnaire - 36-item Short Form health survey (SF-36): Patient-completed health status measure
1.5. Short Orientation Memory Concentration scale (SOMC): measure of orientation, memory and concentration
1.6. Subjective vitality ‘individual difference’ scale: self reported energy levels scale
1.7. Self efficacy scale: confidence to take complete exercise scale
2. Anthropodmetry: weight (kg), height (m) and leg-length (cm) (anterior superior iliac spine to med. Malleolus)
3. Muscle performance: extensor leg power - measurement of leg extension power in sitting
4. Mobility:
4.1. Step count during 8 days measured with a Step Activity Monitor (watch sized device worn on ankle)*
4.2. Timed up and go test (sit to stand from chair and walk 5 metres)
4.3. During 2 minute walk test (walking characteristics (step time and length) recorded with a small accelerometer worn on back)
5. Hydration status: urine analysis
6. Blood test: of neurotrophic factors (proteins associated with brain function) and immune markers*
7. Fitness test:
7.1. Heart Rate (HR): heart rate monitor
7.2. Blood pressure: arm cuff measure
7.3. Rating of perception of effort and symptoms (Breathing and Leg effort): self report
7.4. Enjoyment S-bipolar scale: self report
7.5. Rate of oxygen consumption (metabolism): measurement of expired air
7.6. Muscle response to exercise (blood lactate levels): finger prick (capillary) blood samples
8. Qualative analysis of focus group meetings and interviews

Secondary outcome measures will be measured at baseline, week 6 (half-way intervention), week 12 (end intervention) and week 24 (follow up).

*Neurotrophic factors, immune markers and step activity will only be measured at baseline and end intervention
Overall study start date01/06/2008
Completion date01/10/2009

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexBoth
Target number of participants60
Key inclusion criteria1. Adults (over 18 years, either sex) with Multiple Sclerosis (MS)
2. Able to sit and pedal on a cycle ergometer and complete 60 seconds unloaded exercise
3. Ambulatory with/without a walking aid
Key exclusion criteria1. Serious medical condition or complication that would preclude safe exercise
2. Sudden change/relapse in MS
3. Cognitively unable to consent
Date of first enrolment01/06/2008
Date of final enrolment01/10/2009

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

Movement science group
Oxford
OX10 0SB
United Kingdom

Sponsor information

Oxford Brookes University (UK)
University/education

School of Life Sciences
Gipsy Lane Campus
Headington
Oxford
OX3 0BP
England
United Kingdom

Phone +44 (0)1865 483293
Email lifesciences1@brookes.ac.uk
Website http://www.brookes.ac.uk/
ROR logo "ROR" https://ror.org/04v2twj65

Funders

Funder type

Charity

Multiple Sclerosis Society (UK) (grant ref: 840/06)
Private sector organisation / Associations and societies (private and public)
Alternative name(s)
Multiple Sclerosis Society of Great Britain and Northern Ireland, The MS Society, MS Society UK, Multiple Sclerosis Society UK, MS Society
Location
United Kingdom

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/05/2011 Yes No